ArticleCNS neuroscience & therapeutics2026
Development and Validation of an Interpretable Machine Learning-Based Clinical Prediction Model for Short-Term Mortality in Intracerebral Hemorrhage With Thrombocytopenia: A Multicenter Study.
Article in CNS neuroscience & therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIntracerebral hemorrhage (ICH) with thrombocytopenia is associated with poor outcomes, but early risk prediction tools for this subgroup are limited. We aimed to develop and externally validate an interpretable machine learning model for predicting 28-day all-cause mortality after ICU admission.
methodsInternal data were derived from MIMIC-III/IV, eICU, and NWICU, and external validation data from a single tertiary academic teaching hospital in China. The internal cohort was randomly split 7:3 into internal training set and internal test set. Feature selection, hyperparameter optimization, and training of five machine learning models were performed in the internal training set. Performance was evaluated in the internal test set and external validation cohort. SHAP analysis was used for interpretation, and a web-based tool was developed.
resultsAmong 1190 included patients, 859 were in the internal cohort and 331 in the external validation cohort. Fifteen predictors were retained. LightGBM showed the best performance, with AUROCs of 0.840 and 0.764 in the internal test and external validation cohorts, respectively. Important predictors included GCS, diastolic blood pressure, glucose, and platelet count.
conclusionThe developed LightGBM model showed good internal discrimination, acceptable external discrimination, and interpretable feature contributions, supporting its potential as a complementary early risk stratification aid for patients with ICH and thrombocytopenia. Prospective multicenter validation is required before clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.